Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease.
about
The current role and future prospects of D-dimer biomarkerRelationship of lipoprotein(a) to variables of coagulation in hypertensive subjects.Chlamydia pneumoniae and coronary heart disease.African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertensionTargeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditisNonvalvular atrial fibrillation: evidence for a prothrombotic state.The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease.Fruits and vegetables moderate lipid cardiovascular risk factor in hypertensive patientsHemostasis and thyroid diseases revisited.Inherited thrombophilia.Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice.Do haemostasis activation markers that predict cardiovascular disease exist?Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts.Evaluation of Serum Pregnancy Associated Plasma Protein-A & Plasma D-Dimer in Acute Coronary Syndrome.Hemostatic changes in thyroid diseases: haemostasis and thrombosis.Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.von Willebrand factor and its relevance to cardiovascular disordersHaemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation.Common risk factors for both arterial and venous thrombosis.Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study.Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.Predictive values of D-dimer assay, GRACE scores and TIMI scores for adverse outcome in patients with non-ST-segment elevation myocardial infarction.Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing.Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants.Hypercoagulability and haemodynamic abnormalities in atrial fibrillation.An Aggregate Biomarker Risk Score Predicts High Risk of Near-Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes).Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.Mouse Bone Marrow-Derived Mast Cells Induce Angiogenesis by Tissue Engineering in Rats: Histological Evidence.Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease.D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy.Influence of graft material on blood rheology and plasma biochemistry following insertion of an infrainguinal bypass graft
P2860
Q26741071-F08AF817-DAF6-471F-8A6B-CB768CCD1325Q32056571-642A3F37-8AC2-44E3-A76D-6C0D1A773E58Q33659387-070A2F19-97E8-481A-A85E-CCCE895E86BEQ33804131-4D4CB8F0-BAFC-4552-A3C2-2F8A13097E02Q33849246-AACC845F-25A0-48BE-AE63-4174582E764AQ34025550-37FC231E-E91B-41E9-AA65-A0C93B3AEA95Q34557697-DCD2C579-205D-43FA-9045-5ADB9211FF5BQ34983204-FDF7D7D7-7EFE-45A9-91AA-B1ADA39584E2Q36008326-15EB52DB-BB3B-4704-9D12-6004F117C392Q36021785-D6A66DCF-06E6-487E-BDDE-866CE79073F3Q36030428-6E03E2B2-B257-49C6-AE43-39CAFF2838B4Q36030445-F468E393-7487-4324-9631-04AAC0B91CB7Q36129316-1FB185D4-3D27-4DAD-A8C9-20F9ED0DABEDQ36541763-766F50B6-C09A-4A58-8703-9C5646043FF0Q36746455-92EAB0ED-9712-47C8-B0D9-719D503B22AFQ36820491-87D5365B-ABED-43A4-B385-0A7ED326458FQ36825948-B504EF30-6D28-4729-A3A8-C7C82435EDDAQ36843189-B2668FF2-E8CA-4505-BFFF-1AA9188EAE16Q37084853-2A624674-EDFD-4298-A43B-1C643CC4DC3AQ37144916-34599E93-8886-46DC-B904-E85105EFBCE5Q38747883-2A382EDD-6E27-4C3D-9291-C8174D7621E9Q38837498-DB145880-84F5-4C51-B0B4-81CDE3347CA0Q40810806-EE201D14-5593-47B7-9142-4BA353A449D4Q40864223-4A8437C5-6987-40FB-BAD6-48171D3730BAQ41343151-4D2E65B1-582C-47BE-8229-76069CEC09C2Q41627043-070597AB-79C4-45B3-9FCC-DDDC15F770EEQ44083906-F7FDE2B4-6008-4F35-B694-6714A8149520Q47138763-3CE245F6-73F0-4CA4-BED4-02D71A240E4BQ47638288-39C24974-54D9-4F18-95D0-C447AB762F54Q47833058-48D4162F-98D4-4794-AF0E-AA39B6DBD8B1Q57403364-C5E0BAC4-F4B8-4F7D-899B-59FA89E33030
P2860
Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Cross-linked fibrin degradatio ...... isk of coronary heart disease.
@en
type
label
Cross-linked fibrin degradatio ...... isk of coronary heart disease.
@en
prefLabel
Cross-linked fibrin degradatio ...... isk of coronary heart disease.
@en
P2093
P1433
P1476
Cross-linked fibrin degradatio ...... isk of coronary heart disease.
@en
P2093
F G Fowkes
I R MacGregor
P356
10.1016/0140-6736(93)91288-W
P407
P577
1993-07-01T00:00:00Z